Your browser doesn't support javascript.
loading
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
Seymour, John F; Döhner, Hartmut; Butrym, Aleksandra; Wierzbowska, Agnieszka; Selleslag, Dominik; Jang, Jun Ho; Kumar, Rajat; Cavenagh, James; Schuh, Andre C; Candoni, Anna; Récher, Christian; Sandhu, Irwindeep; Del Castillo, Teresa Bernal; Al-Ali, Haifa Kathrin; Falantes, Jose; Stone, Richard M; Minden, Mark D; Weaver, Jerry; Songer, Steve; Beach, C L; Dombret, Hervé.
Afiliación
  • Seymour JF; Department of Haematology, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett St, East Melbourne, VIC, 8006, Australia. john.seymour@petermac.org.
  • Döhner H; University of Melbourne, Parkville, Australia. john.seymour@petermac.org.
  • Butrym A; Universitätsklinikum Ulm, Ulm, Germany.
  • Wierzbowska A; Wroclaw Medical University, Wroclaw, Poland.
  • Selleslag D; Medical University of Lodz, Lodz, Poland.
  • Jang JH; Algemeen Ziekenhuis Sint-Jan, Brugge, Belgium.
  • Kumar R; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Cavenagh J; Cancer Care Manitoba, Winnipeg, Canada.
  • Schuh AC; Barts Health National Health Service Trust, London, UK.
  • Candoni A; Princess Margaret Cancer Centre, Toronto, Canada.
  • Récher C; Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Sandhu I; Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Del Castillo TB; University of Alberta Hospital, Edmonton, Canada.
  • Al-Ali HK; Hospital Central de Asturias, Oviedo, Spain.
  • Falantes J; University Hospital of Halle, Halle, Germany.
  • Stone RM; Hospital Universitario Virgen del Rocio/Instituto de BioMedicinia de Sevilla, Sevilla, Spain.
  • Minden MD; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Weaver J; Princess Margaret Cancer Centre, Toronto, Canada.
  • Songer S; Celgene Corporation, Summit, NJ, USA.
  • Beach CL; Celgene Corporation, Summit, NJ, USA.
  • Dombret H; Celgene Corporation, Summit, NJ, USA.
BMC Cancer ; 17(1): 852, 2017 Dec 14.
Article en En | MEDLINE | ID: mdl-29241450
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Citarabina / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Azacitidina / Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Citarabina / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Australia